CompletedEARLY_PHASE1NCT06701123

mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder

Sponsor: Washington University School of Medicine

Trial Details

Condition	Opioid Use Disorders
Intervention	uMAT-R mobile app with coaching component
Phase	EARLY_PHASE1
Status	Completed
Participants	125
Est. Completion	1 Oct 2024
Last Updated	3 Apr 2026

Primary Outcome

Cravings; MOUD Attitudes

Eligibility Criteria

Inclusion Criteria

Pregnant and Postpartum Participants: Inclusion Criteria: 1. Pregnant or up to 3 years postpartum 2. Receiving treatment consenting treatment facility and/or referred from other participants or community partners 3. Adult (≥18 years of age) 4. U.S. resident 5. OUD or history of opioid misuse 6. Fluent in English 7. Own a smartphone with an iOS or Android operating system Exclusion Criteria: 1\) Currently incarcerated Providers Inclusion Criteria: 1. Works with pregnant and postpartum people with opioid use disorder and/or at a recovery community center (e.g. a staff person, counselor, social worker, psychiatrist, nurse). 2. Adult (≥18 years of age) 3. Fluent in English 4. Own a smartphone with an iOS or Android operating system

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Completed Pilot Trial: Mobile App uMAT-R Shows Promise for Pregnant Women with Opioid Use Disorder — Digital Therapeutics Evidence Emerges

A completed pilot trial of uMAT-R mobile app shows promise for supporting pregnant and postpartum women with opioid use disorder. The digital therapeutics intervention targeted MAT adherence and cravings management in 125 participants.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service